Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial - Chey, W D; Lembo, A J; Rosenbaum, D P (Am J Gastroenterol, 2017)
. doi:10.1038/ajg.2017.41